Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson’s Disease
Parkinson’s disease (PD) is a complex neurodegenerative disorder featuring both motor and nonmotor symptoms associated with a progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Oxidative stress (OS) has been implicated in the pathogenesis of PD. Genetic and environmental...
Guardado en:
Autores principales: | Yumin Wang, Luyan Gao, Jichao Chen, Qiang Li, Liang Huo, Yanchao Wang, Hongquan Wang, Jichen Du |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/28f5383c4cc645389fe0e568dd9d7b21 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
NRF2 Activation and Downstream Effects: Focus on Parkinson’s Disease and Brain Angiotensin
por: Juan A. Parga, et al.
Publicado: (2021) -
Heme oxygenase 1 overexpression increases iron fluxes in Caco-2 cells
por: MENDIBURO,MARÍA JOSE, et al.
Publicado: (2006) -
HO-1 in Bone Biology: Potential Therapeutic Strategies for Osteoporosis
por: Xueman Zhou, et al.
Publicado: (2021) -
Molecular Hydrogen: Is This a Viable New Treatment for Plants in the UK?
por: John T. Hancock, et al.
Publicado: (2021) -
Autoantibody-Mediated Erythrophagocytosis Increases Tuberculosis Susceptibility in HIV Patients
por: Youchao Dai, et al.
Publicado: (2020)